TrialBlood advances2023

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study.

Won-Seog Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.